CCA
EVH icon

Conestoga Capital Advisors’s Evolent Health EVH Stock Holding History

Conestoga Capital Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-64,340
Closed -$349K – 147
2020
Q1 		$349K Buy
64,340
+1,350
+2% +$12.1K 0.01% 118
2019
Q4 		$570K Buy
62,990
+32,600
+107% +$265K 0.01% 107
2019
Q3 		$219K Hold
30,390
– – 0.01% 140
2019
Q2 		$242K Buy
30,390
+8,070
+36% +$95.5K 0.01% 139
2019
Q1 		$281K Buy
+22,320
New +$353K 0.01% 127

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Conestoga Capital Advisors's EVH Position: Q2 2020 in Review

Conestoga Capital Advisors sold out of Evolent Health (EVH) in Q2 2020, closing a stake of 64,340 shares — an estimated $349K sold.

Conestoga Capital Advisors first reported a position in EVH in Q1 2019 and held it in 5 quarters. The position peaked at $570K in Q4 2019. 136 funds tracked by Wall St. Rank hold EVH as of Q2 2020.

  • Conestoga Capital Advisors reported no remaining Evolent Health position as of Q2 2020 after selling out during the quarter.
  • Conestoga Capital Advisors sold 64,340 Evolent Health shares in Q2 2020, an estimated $349K.
  • Conestoga Capital Advisors first reported a position in Evolent Health in Q1 2019 and held it in 5 quarters.
  • Conestoga Capital Advisors's Evolent Health position peaked at $570K in Q4 2019.
  • 136 funds tracked by Wall St. Rank held Evolent Health as of Q2 2020.

Based on Conestoga Capital Advisors's 13F filing for Q2 2020, filed 3 Aug 2020.